Find clinical trials for Triple Negative Breast Cancer in Chicago, IL

Assess response to pembrolizumab in both primary tumor, normal breast stroma, circulating lymphocytes and serum exosomes in treatme ...

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...

The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer...

and to evaluate the efficacy of this combination in advanced HER2 negative breast cancer that is triple negative...

This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...

oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...

doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...

avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...